Clinical Trials Directory

Trials / Unknown

UnknownNCT01104324

Osteonecrosis in Children With Acute Lymphoblastic Leukemia

Steroid Induced Osteoporosis in the Pediatric Population Ancillary Study- Osteonecrosis in Children With Acute Lymphoblastic Leukemia

Status
Unknown
Phase
Study type
Observational
Enrollment
130 (estimated)
Sponsor
Halton, Jacqueline, M.D. · Academic / Other
Sex
All
Age
5 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Acute lymphoblastic leukemia is the most common form of childhood cancer with current treatment survival rates approaching 80%. Improved outcomes show an increased number of survivors at risk for long-term treatment related side effects including osteonecrosis. Osteonecrosis, or bone death, is caused by blood supply loss to the bone causing pain and poor quality of life. The hips, shoulders, knees and ankles may be affected. Pain is the usual presenting symptom and may become severe requiring surgical decompression or replacement of the affected joint. Long-term effects including arthritis and progressive joint difficulties will not be known for decades. This study aims to determine the risk factors for developing osteonecrosis that will lead to information for earlier detection and prevention. The study will be the basis for future intervention and prevention trials.

Conditions

Timeline

Start date
2009-07-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2010-04-15
Last updated
2010-04-15

Locations

10 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT01104324. Inclusion in this directory is not an endorsement.